✦ LIBER ✦

Omalizumab, an Anti-IgE Monoclonal Antibody, Demonstrates Long-Term Asthma Control, Safety and Tolerability in Patients with Severe Allergic Asthma

✍ Scribed by Hébert, J.; Rolli, M.; Gao, J.; Reisner, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of omalizumab, an anti-IgE anti

✍ DAHL, R 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 26 KB

The effect of treatment with omalizumab,

✍ J. Bousquet; P. Cabrera; N. Berkman; R. Buhl; S. Holgate; S. Wenzel; H. Fox; S. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

Efficacy and tolerability of anti-immuno

✍ J. G. Ayres; B. Higgins; E. R. Chilvers; G. Ayre; M. Blogg; H. Fox 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB

Omalizumab, an anti-IgE antibody, improv

✍ HARNEST, U 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 26 KB